Readystate Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.82M | Buy |
+335,000
| New | +$6.82M | 0.21% | 85 |
|
|
2025
Q1 | – | Sell |
-142,038
| Closed | -$3.59M | – | 416 |
|
|
2024
Q4 | $3.59M | Sell |
142,038
-37,480
| -21% | -$947K | 0.11% | 115 |
|
|
2024
Q3 | $6.1M | Buy |
+179,518
| New | +$6.1M | 0.11% | 74 |
|
|
2024
Q2 | – | Sell |
-49,457
| Closed | -$2.08M | – | 389 |
|
|
2024
Q1 | $2.08M | Buy |
+49,457
| New | +$2.08M | 0.03% | 136 |
|